147 related articles for article (PubMed ID: 25659607)
1. Endocrine implications of neurofibromatosis 1 in childhood.
Bizzarri C; Bottaro G
Horm Res Paediatr; 2015; 83(4):232-41. PubMed ID: 25659607
[TBL] [Abstract][Full Text] [Related]
2. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE; Gutmann DH
Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.
Santoro C; Perrotta S; Picariello S; Scilipoti M; Cirillo M; Quaglietta L; Cinalli G; Cioffi D; Di Iorgi N; Maghnie M; Gallizia A; Parpagnoli M; Messa F; De Sanctis L; Vannelli S; Marzuillo P; Miraglia Del Giudice E; Grandone A
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32294191
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
Cambiaso P; Galassi S; Palmiero M; Mastronuzzi A; Del Bufalo F; Capolino R; Cacchione A; Buonuomo PS; Gonfiantini MV; Bartuli A; Cappa M; Macchiaiolo M
Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895
[TBL] [Abstract][Full Text] [Related]
6. [Developmental manifestation in children with neurofibromatosis type 1].
Cohen R; Shuper A
Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromatosis type I (NF1): peculiarities and complications].
Pascual-Castroviejo I
Rev Neurol; 1996 Sep; 24(133):1051-5. PubMed ID: 8755343
[TBL] [Abstract][Full Text] [Related]
9. Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1.
Petrak B; Bendova S; Seeman T; Klein T; Lisy J; Zatrapa T; Marikova T
Neuro Endocrinol Lett; 2007 Dec; 28(6):734-8. PubMed ID: 18063929
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
12. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
13. [Neurofibromatosis type 1 - description of clinical features and molecular mechanism of the disease].
Bikowska-Opalach B; Jackowska T
Med Wieku Rozwoj; 2013; 17(4):334-40. PubMed ID: 24519776
[TBL] [Abstract][Full Text] [Related]
14. Natural history of neurofibromatosis 1-associated optic nerve glioma in mice.
Bajenaru ML; Garbow JR; Perry A; Hernandez MR; Gutmann DH
Ann Neurol; 2005 Jan; 57(1):119-27. PubMed ID: 15622533
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
Abramowicz A; Gos M
Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393
[TBL] [Abstract][Full Text] [Related]
16. [Endocrine disorders in children with neurofibromatosis von Recklinghausen (author's transl)].
Andler W; Roosen K; Kohns U; Stolecke H
Monatsschr Kinderheilkd (1902); 1979 Mar; 127(3):135-8. PubMed ID: 106238
[TBL] [Abstract][Full Text] [Related]
17. Treatment of neurofibromatosis type 1.
Sabatini C; Milani D; Menni F; Tadini G; Esposito S
Curr Treat Options Neurol; 2015 Jun; 17(6):355. PubMed ID: 25917340
[TBL] [Abstract][Full Text] [Related]
18. [Pheochromocytoma associated with von Recklinghausen neurofibromatosis].
Herrera RN; Miotti JA; Fuentes CM; Robles SP; Amenabar JM; Luciardi HL
Medicina (B Aires); 2007; 67(5):475-7. PubMed ID: 18051232
[TBL] [Abstract][Full Text] [Related]
19. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
